Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ohr Pharma appoints new director

This article was originally published in Scrip

Executive Summary

New York-based Ohr Pharmaceutical, which is currently developing treatments for the wet form of age-related macular degeneration and for cancer cachexia, has appointed Dr Thomas Riedhammer to its board of directors. Most recently, Dr Riedhammer was chair of Sirion Therapeutics. Prior to Sirion, he was chief operating officer at Presby, a medical device company which develops treatments for eye disorders.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts